Please sign in to follow a disease.
Arctic work and heart risk: new study probes hidden dangers
NCT ID NCT05839028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how high blood pressure changes the heart's structure in people who work rotating shifts in the Arctic. Researchers will track 550 workers over a year using heart ultrasounds and blood tests. The goal is to understand why some develop heart failure, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal why some people with high blood pressure develop heart failure, pointing toward future prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly help participants, and the findings may not apply to people outside this specific Arctic work setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 550 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2022
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Зatients with hypertension of stages 1 and 2 and practically healthy individuals living in a temperate climate zone and carrying out an Arctic watch. Hypertension in the Arctic is characterized by faster target organ damage and worse prognosis.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The patient signed the informed consent Exclusion Criteria: * Valvular pathology of the heart * Past cardiac or cerebral complications * Identified heart rhythm disturbances * Coronary heart disease * Patients with severe somatic pathology, whose prognostic survival rate does not exceed 1 year * The presence of a mental disorder of organic origin
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure with preserved ejection fraction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tyumen Cardiology Research Center
Tyumen, Tyumen Oblast, 625026, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Implanted device aims to ease heart failure symptoms
- Can a once-daily pill ease the burden of a common heart failure?
- A glowing dye could expose hidden heart scarring
- Can GLP-1 drugs improve heart function during exercise in Obesity-Related heart failure?
- Could tiny heart vessels hold the key to a common form of heart failure?
- Can a diabetes drug keep the heart in rhythm?